2935
G.-J. Sun et al.
Special Topic
Synthesis
13C NMR (100 MHz, CDCl3): δ = 143.2, 138.8, 138.4, 137.9, 134.2,
133.3, 129.7, 129.6, 127.4, 118.2, 53.9, 21.6, 21.0, 19.1.
N-Allyl-4-methyl-N-[4-(trifluoromethyl)phenyl]benzenesulfon-
amide (3k)12
HRMS (ESI): m/z [M + H]+ calcd for C19H24O2NS: 330.1522; found:
Yield: 36 mg (50%); yellowish solid.
1H NMR (400 MHz, CDCl3): δ = 7.56 (d, J = 8.4 Hz, 2 H), 7.48 (d, J = 8.0
Hz, 2 H), 7.27 (d, J = 8.0 Hz, 2 H), 7.19 (d, J = 8.4 Hz, 2 H), 5.76–5.66 (m,
1 H), 5.11–5.06 (m, 2 H), 4.20 (d, J = 6.4 Hz, 2 H), 2.43 (s, 3 H).
330.1517.
N-Allyl-N-(4-methoxyphenyl)-4-methylbenzenesulfonamide (3f)12
13C NMR (100 MHz, CDCl3): δ = 142.9, 141.3, 134.9, 131.2, 128.6,
Yield: 44 mg (69%); colorless solid.
1H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = 8.4 Hz, 2 H), 7.23 (d, J = 8.4
Hz, 2 H), 6.91 (d, J = 8.8 Hz, 2 H), 6.77 (d, J = 8.8 Hz, 2 H), 5.77–5.67 (m,
1 H), 5.06–5.01 (m, 2 H), 4.12 (d, J = 6.4 Hz, 2 H), 3.76 (s, 3 H), 2.41 (s,
3 H).
13C NMR (100 MHz, CDCl3): δ = 159.0, 143.4, 135.5, 133.0, 131.6,
130.2, 129.4, 127.8, 118.7, 114.1, 55.4, 53.8, 21.6.
127.6, 126.5, 124.9, 118.3, 52.1, 20.5.
N-Allyl-4-methyl-N-2-naphthylbenzenesulfonamide (3l)
Yield: 47 mg (70%); yellowish solid; mp 86–87 °C.
IR (KBr): 3060, 2986, 2920, 2361, 2341, 1596, 1505, 1431, 1342, 1163,
1130, 1110, 1089, 923, 822, 762, 708, 668 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.82–7.80 (m, 1 H), 7.76–7.72 (m, 2 H),
7.53–7.45 (m, 5 H), 7.23 (d, J = 8.0 Hz, 2 H), 7.16–7.13 (m, 1 H), 5.82–
5.72 (m, 1 H), 5.11–5.00 (m, 2 H), 4.27 (d, J = 6.2 Hz, 2 H), 2.42 (s, 3 H).
Ethyl 4-(N-Allyl-4-methylphenylsulfonamido)benzoate (3g)
Yield: 60 mg (84%); yellowish solid; mp 74–75 °C.
13C NMR (100 MHz, CDCl3): δ = 143.5, 136.5, 135.5, 133.3, 132.8,
132.5, 129.5, 128.7, 128.0, 127.8, 127.7, 127.6, 126.6, 126.5, 126.4,
118.9, 53.6, 21.6.
HRMS (ESI): m/z [M + H]+ calcd for C20H20O2NS: 338.1209; found:
338.1207.
IR (KBr): 3051, 2090, 1708, 1648, 1604, 1506, 1494, 1468, 1399, 1368,
1352, 1275, 1166, 1110, 1060, 935, 876, 814, 707 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.97 (d, J = 8.4 Hz, 2 H), 7.36 (d, J = 8.4
Hz, 2 H), 7.25 (d, J = 8.4 Hz, 2 H), 7.14 (d, J = 8.8 Hz, 2 H), 5.76–5.66 (m,
1 H), 5.10–5.04 (m, 2 H), 4.40–4.31 (m, 2 H), 4.21 (d, J = 6.0 Hz, 2 H),
2.42 (s, 3 H), 1.38 (t, J = 7.2 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 165.9, 143.8, 143.3, 135.0, 132.4,
N-Allyl-N-benzyl-4-methylbenzenesulfonamide (3m)13
130.2, 129.6, 129.4, 128.0, 127.6, 119.2, 61.2, 53.0, 21.6, 14.3.
HRMS (ESI): m/z [M + H]+ calcd for C19H22O4NS: 360.1264; found:
360.1259.
Yield: 43 mg (71%); colorless solid.
1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.4 Hz, 2 H), 7.28–7.19 (m, 7
H), 5.47–5.37 (m, 1 H), 5.02–4.92 (m, 2 H), 4.34 (s, 2 H), 3.70 (d, J = 6.4
Hz, 2 H), 2.39 (s, 3 H).
N-Allyl-N-(4-fluorophenyl)-4-methylbenzenesulfonamide (3h)12
13C NMR (100 MHz, CDCl3): δ = 142.3, 136.5, 135.0, 131.2, 128.7,
Yield: 55 mg (90%); white solid.
127.5, 126.7, 126.2, 118.3, 49.1, 48.4, 20.5.
1H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = 8.4 Hz, 2 H), 7.26 (d, J = 8.0
Hz, 2 H), 7.01–6.94 (m, 4 H), 5.77–5.67 (m, 1 H), 5.07–5.03 (m, 2 H),
4.14 (d, J = 6.0 Hz, 2 H), 2.43 (s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 162.0, 159.6, 142.6, 134.2, 133.9,
131.6, 129.7, 126.7, 118.1, 114.9, 114.7, 52.7, 20.5.
N-{4-[Allyl(tosyl)amino]phenyl}acetamide (3n)
Yield: 28 mg (41%); yellowish solid; mp 54–55 °C.
IR (KBr): 3311, 3061, 2922, 1671, 1600, 1536, 1510, 1469, 1408, 1344,
1311, 1161, 1090, 869, 813, 716, 662 cm–1
.
1H NMR (400 MHz, DMSO-d6): δ = 10.02 (s, 1 H), 7.50–7.38 (m, 6 H),
6.94 (d, J = 8.8 Hz, 2 H), 5.71–5.61 (m, 1 H), 5.14–5.02 (m, 2 H), 4.14 (t,
J = 5.6 Hz, 2 H), 2.40 (s, 3 H), 2.03 (s, 3 H).
N-Allyl-N-(4-chlorophenyl)-4-methylbenzenesulfonamide (3i)12
Yield: 46 mg (71%); white powder.
1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 8.4 Hz, 2 H), 7.27–7.24 (m, 4
H), 7.00 (d, J = 8.8 Hz, 2 H), 5.75–5.67 (m, 1 H), 5.08–5.04 (m, 2 H),
4.13 (d, J = 6.0 Hz, 2 H), 2.43 (s, 3 H).
13C NMR (100 MHz, DMSO-d6): δ = 168.9, 143.9, 139.0, 135.3, 133.6,
133.5, 130.2, 129.3, 119.4, 119.2, 53.1, 24.4, 21.5.
HRMS (ESI): m/z [M + H]+ calcd for C18H21O3N2S: 345.1267; found:
345.1262.
13C NMR (100 MHz, CDCl3): δ = 143.7, 137.6, 135.1, 133.6, 132.5,
130.1, 129.6, 129.1, 127.7, 119.2, 53.4, 21.6.
N-Allyl-4-methyl-N-(2-pyridyl)benzenesulfonamide (3o)
Yield: 22 mg (39%); yellowish solid; mp 75–77 °C.
N-Allyl-N-(3-chlorophenyl)-4-methylbenzenesulfonamide (3j)
Yield: 52 mg (81%); white powder; mp 76–77 °C.
IR (KBr): 3092, 3056, 2920, 2853, 1633, 1599, 1555, 1503, 1456, 1370,
1353, 1283, 1266, 1167, 1137, 1084, 972, 914, 827, 766, 660 cm–1
.
IR (KBr): 3075, 2979, 2921, 1586, 1492, 1472, 1420, 1163, 1092, 1071,
1013, 930, 889, 804, 702, 682, 668 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.83 (d, J = 8.0 Hz, 2 H), 7.71–7.68 (m, 1
H), 7.50–7.47 (m, 2 H), 7.23 (d, J = 8.0 Hz, 2 H), 6.54–6.51 (m, 1 H),
6.01–5.92 (m, 1 H), 5.31–5.28 (m, 2 H), 4.77 (d, J = 6.0 Hz, 2 H), 2.38 (s,
3 H).
1H NMR (400 MHz, CDCl3): δ = 7.49 (d, J = 8.4 Hz, 2 H), 7.28–7.20 (m, 4
H), 7.05–7.04 (m, 1 H), 7.00–6.94 (m, 1 H), 5.76–5.66 (m, 1 H), 5.10–
5.06 (m, 2 H), 4.14 (d, J = 6.3 Hz, 2 H), 2.43 (s, 3 H).
13C NMR (100 MHz, CDCl3): δ = 143.9, 140.4, 135.1, 134.3, 132.5,
13C NMR (100 MHz, CDCl3): δ = 155.5, 141.7, 140.8, 140.1, 138.2,
129.8, 129.6, 129.0, 128.1, 127.8, 127.0, 119.3, 53.5, 21.6.
131.1, 129.1, 126.4, 120.0, 118.3, 110.8, 54.9, 21.5.
HRMS (ESI): m/z [M + H]+ calcd for C16H17O2NClS: 322.0663; found:
HRMS (ESI): m/z [M + H]+ calcd for C15H17O2N2S: 289.1005; found:
322.0658.
289.1000.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2015, 47, 2931–2936